AROPAX CR 12.50 TAB

Product Description

AROPAX CR 12.50 TAB Paroxetine 12.5mg | Controlled-Release Antidepressant for Mood & Anxiety Disorders

Product Overview:
AROPAX CR 12.50 TAB contains Paroxetine 12.5mg in a controlled-release (CR) formulation, designed for the effective treatment of depression, anxiety disorders, and obsessive-compulsive disorder (OCD). With its gradual release mechanism, it ensures steady therapeutic levels, reduced side effects, and enhanced patient compliance. A preferred choice for psychiatrists and neurologists, this product is suitable for hospitals, mental health clinics, and retail pharmacies.

Key Benefits:

• Controlled Release Technology: Ensures consistent drug levels and improved tolerability.

• Broad Spectrum Usage: Indicated for major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety, panic disorder, and OCD.

• Clinically Trusted SSRI: Offers reliable symptom control with a well-established safety profile.

• Improved Patient Compliance: Once-daily dosage with fewer gastrointestinal side effects.

Usage & Indications:
Recommended for the treatment of psychiatric conditions like depression, panic attacks, social phobia, PTSD, and chronic anxiety, especially where long-term medication adherence is crucial.

Target Audience:
Best suited for psychiatric drug distributors, B2B pharma wholesalers, hospital procurement departments, and mental healthcare providers seeking a reliable SSRI antidepressant for bulk supply.

Packaging & Supply:
Available in tamper-proof blister packaging with bulk and private label options. Compliant with international quality norms and suitable for domestic and export markets.

Connect with us today for bulk orders of AROPAX CR 12.50 TAB your trusted solution in neuropsychiatric care. Competitive rates, timely delivery, and full B2B support guaranteed.